One might accept a higher chance
of a false positive result in a preliminary study, for instance, whereas a drug trial might require a lower p - value.
However, the
rate of false positive results is likely to increase when testing is performed on animals without clinical signs or who have not come from a high - risk situation.
They suggest most women in their 40s should not have routine mammograms because the tests may cause more harm than good
because of false positive results (follow - up testing proves negative for cancer).
In addition, more than half of women who get annual screenings for 10 years can expect to have a false positive mammogram that requires additional images, and about 20
percent of these false positives result in unnecessary biopsies.
After any heartworm treatment, the antigen heartworm tests have a greater
incidence of false positive results since the test is for antigens that are released from dead heartworms as well as live heartworms.
Used in conjunction with mammography, imaging based on nuclear medicine is currently being used as a successful secondary screening alongside mammography to reduce the
number of false positive results in women with dense breasts and at higher risk for developing breast cancer.
Compared to conventional RT - PCR, real - time RT - PCR has several advantages such as rapidity, low risk
of false positive results, high sensitivity, specificity and the possibility of quantitative measurements.
In healthy, low - risk populations FIV is quite uncommon, and this leads to an increase in the relative number
of false positive results.
Unlike PRCD tests offered for other breeds, this marker test is specific for Tollers and results in a greatly reduced chance (0.05 percent or less)
of false positive results.
Professors Caroline de Costa and Jan Dickinson wrote an editorial in the MJA calling for the test to be more widely available Professor de Costa told the ABC that «one of problems with existing technology is that there are a certain number
of false positive results.»